Cognitive impairment in nondemented Parkinson's disease

被引:106
作者
Barone, Paolo [1 ,2 ]
Aarsland, Dag [3 ,4 ]
Burn, David [5 ]
Emre, Murat [6 ]
Kulisevsky, Jaime [7 ,8 ]
Weintraub, Daniel [9 ]
机构
[1] Univ Naples Federico 2, Dipartimento Sci Neurol, ICD Hermitage, I-80131 Naples, Italy
[2] Univ Salerno, Salerno, Italy
[3] Stavanger Univ Hosp, Div Psychiat, Stavanger, Norway
[4] Univ Oslo, Akerhus Univ Hosp, Stavanger, Norway
[5] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[6] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
[7] Hosp St Pau IIB St Pau, Dept Neurol, CIBERNED, Barcelona, Spain
[8] Autonomous Univ Barcelona, Barcelona, Spain
[9] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
Parkinson's disease; CIND-PD; mild cognitive impairment; symptoms; assessment; DEEP BRAIN-STIMULATION; DEMENTIA RATING-SCALE; MINI-MENTAL-STATE; PROGRESSIVE SUPRANUCLEAR PALSY; CSF AMYLOID-BETA; VISUAL HALLUCINATIONS; NEUROPSYCHIATRIC SYMPTOMS; DOPAMINERGIC MODULATION; ALZHEIMERS-DISEASE; MEMORY DEFICITS;
D O I
10.1002/mds.23919
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are reported to be affected by cognitive impairment (CI). In practice, however, CI is underrecognized, as the signs may not be apparent in early-stage disease and many routine assessment tools lack the sensitivity to detect subtle cognitive dysfunction. Patients with PD and mild CI (MCI) may have a higher risk of developing dementia than cognitively intact PD patients; however, it is not currently known which patients with CI are at increased risk of developing dementia. This review summarizes current knowledge about CI in nondemented PD; it discusses the structural and functional changes associated with CI and addresses areas of unmet needs. We focus on questions that should be addressed in future studies to achieve consensus on its characteristics and definition, pathophysiology, epidemiology, diagnosis and assessment, and treatment and management. (c) 2011 Movement Disorder Society
引用
收藏
页码:2483 / 2495
页数:13
相关论文
共 131 条
[1]   The rate of cognitive decline in Parkinson disease [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Perry, R ;
Wentzel-Larsen, T ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2004, 61 (12) :1906-1911
[2]   Risk of dementia in Parkinson's disease - A community-based, prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Nielsen, H ;
Kragh-Sorensen, P .
NEUROLOGY, 2001, 56 (06) :730-736
[3]   Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease [J].
Aarsland, D ;
Litvan, I ;
Salmon, D ;
Galasko, D ;
Wentzel-Larsen, T ;
Larsen, JP .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (09) :1215-1220
[4]   Mild cognitive impairment in Parkinson disease A multicenter pooled analysis [J].
Aarsland, D. ;
Bronnick, K. ;
Williams-Gray, C. ;
Weintraub, D. ;
Marder, K. ;
Kulisevsky, J. ;
Burn, D. ;
Barone, P. ;
Pagonabarraga, J. ;
Allcock, L. ;
Santangelo, G. ;
Foltynie, T. ;
Janvin, C. ;
Larsen, J. P. ;
Barker, R. A. ;
Emre, M. .
NEUROLOGY, 2010, 75 (12) :1062-1069
[5]   Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study [J].
Aarsland, D. ;
Bronnick, K. ;
Larsen, J. P. ;
Tysnes, O. B. ;
Alves, G. .
NEUROLOGY, 2009, 72 (13) :1121-1126
[6]   Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress [J].
Aarsland, D. ;
Bronnick, K. ;
Ehrt, U. ;
De Deyn, P. P. ;
Tekin, S. ;
Emre, M. ;
Cummings, J. L. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01) :36-42
[7]   Mild Cognitive Impairment in Parkinson's Disease [J].
Aarsland, Dag ;
Bronnick, Kolbjorn ;
Fladby, Tormod .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (04) :371-378
[8]   Dementia in Parkinson's disease [J].
Aarsland, Dag ;
Beyer, Mona K. ;
Kurz, Martin W. .
CURRENT OPINION IN NEUROLOGY, 2008, 21 (06) :676-682
[9]   CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study [J].
Alves, Guido ;
Bronnick, Kolbjorn ;
Aarsland, Dag ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Ballard, Clive ;
Kurz, Martin Wilhelm ;
Andreasson, Ulf ;
Tysnes, Ole-Bjorn ;
Larsen, Jan Petter ;
Mulugeta, Ezra .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (10) :1080-1086
[10]  
Amboni M, 2009, MOVEMENT DISORD, V24, pS233